Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antipsychotic Treatment”

Showing 20 of 0 results

Not applicableUnknownNCT06238089
What this trial is testing

Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales

Who this might be right for
Intellectual Disability
University of Plymouth 600
Not applicableStudy completedNCT01686815
What this trial is testing

Cross-Sectional Iloperidone IVGTT

Who this might be right for
SchizophreniaSerious Mental IllnessMetabolic Syndrome+2 more
Massachusetts General Hospital 37
Testing effectiveness (Phase 2)Active Not RecruitingNCT02926859
What this trial is testing

Enhancing Recovery in Early Schizophrenia

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 180
Large-scale testing (Phase 3)Study completedNCT00210548
What this trial is testing

Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 366
Not applicableUnknownNCT01966588
What this trial is testing

Adverse Events and Genomics in Schizophrenia

Who this might be right for
Adverse Effect of Other Antipsychotics and Neuroleptics
University of British Columbia 100
Testing effectiveness (Phase 2)Ended earlyNCT00977522
What this trial is testing

PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 207
Not applicableActive Not RecruitingNCT06838104
What this trial is testing

Effect of Melatonin on Schizophrenic Symptoms: a Randomized Placebo-Controlled Trial

Who this might be right for
Schizophrenia DisordersPsychotic Disorder
Lahore General Hospital 76
Post-approval studies (Phase 4)Study completedNCT00595504
What this trial is testing

Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Massachusetts General Hospital 25
Post-approval studies (Phase 4)Study completedNCT00140426
What this trial is testing

A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa

Who this might be right for
Anorexia Nervosa
University of Colorado, Denver 41
Early research (Phase 1)UnknownNCT01259973
What this trial is testing

Typical Versus Atypical Antipsychotics; Occupation of Striatal Receptors and the Appearance of Extrapyramidal Symptomatology, in Healthy Volunteers

Who this might be right for
PharmacogeneticsHealthy
Hospital Clinic of Barcelona 24
Large-scale testing (Phase 3)Ended earlyNCT00533455
What this trial is testing

Gabapentin for the Treatment of Neuroleptic-Induced Tremor

Who this might be right for
Neuroleptic-Induced Tremor
Minneapolis Veterans Affairs Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00681668
What this trial is testing

Quetiapine in Postpartum Depression

Who this might be right for
Postpartum Depressive Disorder
AstraZeneca 5
Early research (Phase 1)Study completedNCT00838669
What this trial is testing

The Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 74
Large-scale testing (Phase 3)Study completedNCT00202280
What this trial is testing

Efficacy of Treating First Episode Psychosis With Folic Acid,B12 and B6 in Addition to Antipsychotic Medication

Who this might be right for
First Episode Psychosis
Melbourne Health 120
Post-approval studies (Phase 4)WithdrawnNCT02286206
What this trial is testing

Study of the Effect of Dosing on Clozapine Levels

Who this might be right for
Psychotic DisordersSchizophrenia
University of British Columbia
Not applicableStudy completedNCT00809731
What this trial is testing

Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment

Who this might be right for
Schizophrenia
AstraZeneca 490
Post-approval studies (Phase 4)Study completedNCT00545467
What this trial is testing

Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents

Who this might be right for
DSM-IV SchizophreniaSchizoaffective Disorder
National Taiwan University Hospital 79
Testing effectiveness (Phase 2)Study completedNCT06179108
What this trial is testing

Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

Who this might be right for
Schizophrenia
LB Pharmaceuticals Inc. 359
Large-scale testing (Phase 3)Study completedNCT02013609
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment

Who this might be right for
MDD
Otsuka Pharmaceutical Development & Commercialization, Inc. 48
Large-scale testing (Phase 3)Study completedNCT00253149
What this trial is testing

The Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Who this might be right for
Bipolar DisordersManic Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 158
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation